Claritev Corporation (CTEV)
NYSE: CTEV · Real-Time Price · USD
38.65
-1.74 (-4.31%)
Jul 29, 2025, 4:00 PM - Market closed
Claritev Market Cap
Claritev has a market cap or net worth of $635.27 million as of July 30, 2025. Its market cap has increased by 153.05% in one year.
Market Cap
635.27M
Enterprise Value
5.25B
1-Year Change
153.05%
Ranking
Category
Stock Price
$38.65
Market Cap Chart
Since April 3, 2020, Claritev's market cap has increased from $243.00M to $635.27M, an increase of 161.43%. That is a compound annual growth rate of 19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2025 | 635.27M | 165.79% |
| Dec 31, 2024 | 239.01M | -74.44% |
| Dec 29, 2023 | 935.26M | 27.25% |
| Dec 30, 2022 | 734.99M | -74.01% |
| Dec 31, 2021 | 2.83B | -46.98% |
| Dec 31, 2020 | 5.33B | 2,094.66% |
| Apr 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.93B |
| Johnson & Johnson | 404.87B |
| AbbVie | 337.77B |
| Novo Nordisk | 238.11B |
| UnitedHealth Group | 236.83B |
| AstraZeneca | 230.79B |
| Novartis AG | 227.32B |
| Abbott Laboratories | 222.72B |